XASX
DOC
Market cap19mUSD
Apr 11, Last price
0.09AUD
1D
0.00%
1Q
11.69%
IPO
-90.06%
Name
Doctor Care Anywhere Group PLC
Chart & Performance
P/E
—
P/S
0.39
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
39m
+2.26%
Net income
-6m
L-37.40%
CFO
353k
P
Earnings
Apr 22, 2025
Profile
Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland. It offers services in the areas of appointments, patient records, prescriptions, referrals and fit notes, service improvements, and virtual GP consultations in the form of video and phone. The company provides treatments for allergies, bites and stings, cold and flu, headaches and migraines, joint pains, lifestyle support, mental and sexual health, skin conditions, and stomach and digestive problems, as well as offers virtual healthcare, technology platform licensing, and digital design services. It serves medical insurers, employers, retailers, healthcare providers, and direct sales to the public. The company was incorporated in 2013 and is headquartered in London, the United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | 39,333 2.26% | 38,462 26.44% | 30,418 18.88% | |||
Cost of revenue | 41,179 | 43,837 | 49,989 | |||
Unusual Expense (Income) | ||||||
NOPBT | (1,846) | (5,375) | (19,571) | |||
NOPBT Margin | ||||||
Operating Taxes | (135) | (695) | (257) | |||
Tax Rate | ||||||
NOPAT | (1,711) | (4,680) | (19,314) | |||
Net income | (6,291) -37.40% | (10,049) -54.39% | (22,033) 8.99% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 6,069 | |||||
BB yield | -35.07% | |||||
| Debt | ||||||
Debt current | 206 | 4,238 | 619 | |||
Long-term debt | 8,270 | 6,947 | 1,100 | |||
Deferred revenue | ||||||
Other long-term liabilities | 750 | 956 | 1,375 | |||
Net debt | 3,048 | 1,790 | (5,653) | |||
| Cash flow | ||||||
Cash from operating activities | 353 | (6,341) | (22,033) | |||
CAPEX | (6) | (2,344) | ||||
Cash from investing activities | (1,651) | (2,237) | (2,344) | |||
Cash from financing activities | (332) | 9,316 | 5,904 | |||
FCF | (1,562) | (3,863) | (18,640) | |||
| Balance | ||||||
Cash | 5,288 | 8,095 | 5,406 | |||
Long term investments | 140 | 1,300 | 1,966 | |||
Excess cash | 3,461 | 7,472 | 5,851 | |||
Stockholders' equity | (56,857) | (53,880) | 12,288 | |||
Invested Capital | 65,232 | 67,961 | 8,431 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 314,550 | 366,672 | 360,503 | |||
Price | 0.08 20.97% | 0.06 29.17% | 0.05 -92.44% | |||
Market cap | 23,591 3.77% | 22,734 31.38% | 17,304 -91.55% | |||
EV | 26,639 | 24,524 | 11,651 | |||
EBITDA | 369 | (5,375) | (15,889) | |||
EV/EBITDA | 72.19 | |||||
Interest | 828 | 507 | 77 | |||
Interest/NOPBT | ||||||